Clinuvel Pharmaceuticals (UR9) Ownership - Who Owns Clinuvel Pharmaceuticals ?
Clinuvel Pharmaceuticals (UR9) Ownership Overview
- 2.97% Mutual Funds
- 3.28% ETFs
- 93.75% Public Companies and Individual Investors
The ownership structure of Clinuvel Pharmaceuticals (DE:UR9) stock is a mix of institutional, retail, and individual investors. Approximately 6.25% of the company’s stock is owned by Institutional Investors, and 93.75% is owned by Public Companies and Individual Investors.
The ownership structure of Clinuvel Pharmaceuticals (DE:UR9) stock is a mix of institutional, retail, and individual investors. Approximately 97.03% of the company’s stock is owned by Institutional Investors, 2.97% is owned by Insiders
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,306,934 | Institution | 2.59% | 6,486,313 |
| Vanguard Star Funds | 567,868 | Institution | 1.12% | 2,818,329 |
| Vanguard Tax-managed Funds | 415,309 | Institution | 0.82% | 2,061,179 |
| Vanguard International Equity Index Funds | 284,635 | Institution | 0.56% | 1,412,644 |
| Dfa Investment Dimensions Group Inc | 224,204 | Institution | 0.44% | 1,112,724 |
| Dimensional | 147,125 | Institution | 0.29% | 730,181 |
| Schwab | 93,737 | Institution | 0.19% | 465,217 |
| State Street | 46,080 | Institution | 0.09% | 228,695 |
| Avantis | 39,019 | Institution | 0.08% | 193,651 |
| Ishares | 20,432 | Institution | 0.04% | 101,404 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 567,868 | Institution | 1.12% | 2,818,329 |
| Vanguard Tax-managed Funds | 415,309 | Institution | 0.82% | 2,061,179 |
| Vanguard International Equity Index Funds | 284,635 | Institution | 0.56% | 1,412,644 |
| Dfa Investment Dimensions Group Inc | 224,204 | Institution | 0.44% | 1,112,724 |
| Hussman Investment Trust | 5,000 | Institution | <0.01% | 24,815 |
| John Hancock Variable Insurance Trust | 2,335 | Institution | <0.01% | 11,589 |
| Franklin Alternative Strategies Funds | 2 | Institution | <0.01% | 10 |
FAQ
What percentage of Clinuvel Pharmaceuticals (DE:UR9) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.75% of Clinuvel Pharmaceuticals (DE:UR9) stock is held by retail investors.
Who owns the most shares of Clinuvel Pharmaceuticals (DE:UR9)?
Vanguard owns the most shares of Clinuvel Pharmaceuticals (DE:UR9).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.